{
    "title": "Youth Opioid Use Treatment Help Act of 2017",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Youth Opioid Use Treatment Help Act \nof 2017'' or the ``YOUTH Act''.\n\nSEC. 2. REAUTHORIZATION OF SUBSTANCE ABUSE TREATMENT SERVICES FOR \n              CHILDREN, ADOLESCENTS, AND YOUNG ADULTS.\n\n    Section 514 of the Public Health Service Act (42 U.S.C. 290bb-7) is \namended--\n            (1) in the section heading, by striking ``children and \n        adolescents'' and inserting ``children, adolescents, and young \n        adults'';\n            (2) in subsection (a)(2), by striking ``children, \n        including'' and inserting ``children, adolescents, and young \n        adults, including''; and\n            (3) by striking ``children and adolescents'' each place it \n        appears and inserting ``children, adolescents, and young \n        adults''.\n\nSEC. 3. ACCESS TO MEDICATION-ASSISTED TREATMENT FOR ADOLESCENTS AND \n              YOUNG ADULTS DEMONSTRATION PROGRAM.\n\n    (a) In General.--The Secretary of Health and Human Services, acting \nthrough the Director of the Agency for Healthcare Research and Quality \n(in this section referred to as the ``Director''), shall award grants \nto eligible entities to establish demonstration programs to--\n            (1) expand access to medication-assisted treatment for \n        opioid use disorders among adolescents and young adults;\n            (2) identify and test solutions for overcoming barriers to \n        implementation of medication-assisted treatment for adolescents \n        and young adults; or\n            (3) create and distribute resources on medication-assisted \n        treatment training and implementation for providers of health \n        care to children, adolescents, and young adults.\n    (b) Eligible Entities.--To be eligible to receive a grant under \nsubsection (a), an entity shall--\n            (1) be a State, political subdivision of a State, Indian \n        tribe, or tribal organization, professional family medicine \n        provider organization, professional pediatric provider \n        organization or other organization representing providers of \n        health care to children, adolescents, and young adults, \n        professional addiction medicine provider organization, \n        hospital, an institution of higher education, or other \n        appropriate public or nonprofit institution; and\n            (2) certify that it is in compliance with all applicable \n        registration and licensing requirements.\n    (c) Application.--To seek a grant under this section, an entity \nshall submit to the Director an application at such time, in such \nmanner, and containing such information as the Director may require.\n    (d) Duration.--An eligible entity may receive funds under this \nsection to carry out a demonstration program described in this section \nfor a period of not greater than 3 years. After the first year for \nwhich funding is provided to an eligible entity for a demonstration \nprogram, funding may be provided under this section for a subsequent \nyear for such program only upon review of such program by the Director \nand approval by the Director of such subsequent year of funding.\n    (e) Reports.--\n            (1) By grant recipients.--Each eligible entity awarded a \n        grant under this section for a demonstration program shall \n        submit to the Director progress reports on such demonstration \n        program at such times, in such manner, and containing such \n        information as the Director may require.\n            (2) By director.--Not later than one year after the date on \n        which all demonstration programs funded under this section have \n        been completed, the Director shall submit to the Committee on \n        Health, Education, Labor, and Pensions of the Senate, and the \n        Committee on Energy and Commerce of the House of \n        Representatives a report that--\n                    (A) describes the availability of medication-\n                assisted treatment for adolescents and young adults \n                with opioid use disorders in the United States, \n                including barriers to such treatment;\n                    (B) describes the specific demonstration programs \n                carried out pursuant to this section;\n                    (C) evaluates the effectiveness of such programs;\n                    (D) evaluates any unintended consequences of such \n                programs; and\n                    (E) provides recommendations for ensuring that \n                medication-assisted treatment is accessible to \n                adolescents and young adults with opioid use disorders.\n    (f) Definitions.--In this section:\n            (1) The phrase ``adolescents and young adults'' means \n        individuals who have attained 10 years of age and not yet \n        attained 26 years of age.\n            (2) The term ``medication-assisted treatment'' means the \n        combination of pharmacological treatments approved by the Food \n        and Drug Administration, and counseling and behavioral \n        therapies, for the treatment of substance use disorders.\n            (3) The term ``opioid use disorder'' means a problematic \n        pattern of opioid use leading to clinically significant \n        impairment or distress occurring within a 12-month period.\n            (4) The term ``pediatric health care provider'' means a \n        provider of health care to individuals who have attained 10 \n        years of age and not yet attained 26 years of age.\n            (5) The term ``professional family medicine provider \n        organization'' means a national organization whose members \n        consist primarily of family medicine providers.\n            (6) The term ``professional pediatric provider \n        organization'' means a national organization whose members \n        consist primarily of pediatric health care providers.\n    (g) Authorization of Appropriations.--There is authorized to be \nappropriated $5,000,000 to carry out this section."
}